Effects of NSAIDs on the risk factors of colorectal cancer: A mini review

被引:25
作者
Hamoya T. [1 ,2 ]
Fujii G. [3 ]
Miyamoto S. [1 ]
Takahashi M. [4 ]
Totsuka Y. [3 ]
Wakabayashi K. [5 ]
Toshima J. [2 ]
Mutoh M. [1 ,3 ]
机构
[1] Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo
[2] Department of Biological Science and Technology, Tokyo University of Science, 6-3-1 Niijuku, Katsusika-ku, Tokyo
[3] Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo
[4] Central Animal Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo
[5] Graduate Division of Nutritional and Environmental Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka
基金
日本学术振兴会;
关键词
Chemoprevention; Colorectal cancer; Non-steroidal anti-inflammatory drugs; Risk factors;
D O I
10.1186/s41021-016-0033-0
中图分类号
学科分类号
摘要
Evidence from epidemiological and experimental studies has shown that non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colorectal cancer (CRC). The function of NSAIDs and the molecular targets for chemopreventive effects on CRC have been extensively studied and their data were reported. However, the relation between NSAIDs and the risk factors of CRC have not been fully elucidated yet. Thus, relations between NSAIDs and the risk factors of CRC, such as overweight and obesity, alcohol, aging, hypertriglyceridemia and smoking, are summarized with our data and with recent reported data in this review. © 2016 Hamoya et al.
引用
收藏
相关论文
共 66 条
[1]  
Rothwell P.M., Wilson M., Elwin C.E., Norrving B., Algra A., Warlow C.P., Et al., Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials, Lancet., 376, pp. 1741-1750, (2010)
[2]  
Komiya M., Fujii G., Takahashi M., Iigo M., Mutoh M., Prevention and intervention trials for colorectal cancer, Japanese J Clin Oncol., 43, pp. 685-694, (2013)
[3]  
American Institute for Cancer Research, Food, Nutrition and the Prevention of Cancer: A Global Perspective, (2007)
[4]  
Niccoli T., Partridge L., Ageing as a risk factor for disease, Curr Biol., 22, pp. R741-R752, (2012)
[5]  
Inoue M., Noda M., Kurahashi N., Iwasaki M., Sasazuki S., Iso H., Et al., Impact of metabolic factors on subsequent cancer risk: Results from a large-scale population-based cohort study in Japan, Eur J Cancer Prev., 18, pp. 240-247, (2009)
[6]  
Otani T., Iwasaki M., Ikeda S., Kozu T., Saito H., Mutoh M., Et al., Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees, Cancer Causes and Control, 17, pp. 1245-1252, (2006)
[7]  
Yee Y.K., Tan V.P.Y., Chan P., Hung I.F.N., Pang R., Wong B.C.Y., Epidemiology of colorectal cancer in Asia, J Gastroenterol Hepatol, 24, pp. 1810-1816, (2009)
[8]  
Matsuo K., Mizoue T., Tanaka K., Tsuji I., Sugawara Y., Sasazuki S., Et al., Association between body mass index and the colorectal cancer risk in Japan: Pooled analysis of population-based cohort studies in Japan, Ann Oncol., 23, pp. 479-490, (2012)
[9]  
Goh L.Y., Goh K.L., Obesity: An epidemiological perspective from Asia and its relationship to gastrointestinal and liver cancers, J Gastroenterol Hepatol, 28, pp. 54-58, (2013)
[10]  
Nagata N., Sakamoto K., Arai T., Niikura R., Shimbo T., Shinozaki M., Et al., Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma, Int J Cancer, 135, pp. 2273-2281, (2014)